Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation-Reference-Cited by-同舟云学术

Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Published:2021-05 Issue:5 Volume:27 Page:408.e1-408.e6
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Rank Andreas,Peczynski Christophe,Labopin Myriam,Stelljes Matthias,Simand Celestine,Helbig Grzegorz,Finke Jürgen,Santarone Stella,Tischer Johanna,Lange Andrzej,Mistrik Martin,Houhou Mohamed,Schmid Christoph,Nagler Arnon,Mohty Mohamad

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference25 articles.

1. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Dohner;Blood,2017

2. Who should receive a transplant for acute lymphoblastic leukaemia?;Dhawan;Curr Hematol Malig Rep,2017

3. Proceedings from the National Cancer Institute’s Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: Part III. Prevention and Treatment of Relapse after Allogeneic Transplantation

4. Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse;Kharfan-Dabaja;JAMA Oncol,2018

5. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation;Levine;J Clin Oncol,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies;Annals of Hematology;2024-07-14

2. Advances in second hematopoietic stem cell transplantation;Frontiers in Immunology;2024-07-09

3. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

4. Third HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide for relapsed acute leukemia;Bone Marrow Transplantation;2023-09-15

5. Reducing Mortality of Single-Unit Unrelated Cord Blood Transplantation for Relapsed Acute Myeloid Leukemia after a Previous Allogeneic Transplantation: A Real-World Retrospective Study Over the Past 19 Years in Japan;Transplantation and Cellular Therapy;2022-11